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ABSTRACT The renin-angiotensin system plays an essential role in blood pressure
homeostasis. Because renin activity is reﬂected as a blood pressure phenotype, its
gene expression in the kidney is tightly regulated by a feedback mechanism; i.e.,
renin gene transcription is suppressed in a hypertensive state. To address the molec-
ular mechanisms controlling hypertension-responsive mouse renin (mRen) gene reg-
ulation, we deleted either 5= (17-kb) or 3= (78-kb) regions of the endogenous mRen
gene and placed the animals in a hypertensive environment. While the mRen gene
bearing the 3= deletion was appropriately downregulated, the one bearing the 5=
deletion lost this hypertension responsiveness. Because the 17-kb sequence exhib-
ited enhancer activity in vivo and in vitro, we narrowed down the enhancer to a
2.3-kb core using luciferase assays in As4.1 cells. When this 2.3-kb sequence was re-
moved from the endogenous mRen gene in the mouse, its basal expression was dra-
matically reduced, and the hypertension responsiveness was signiﬁcantly attenuated.
Furthermore, we demonstrated that the angiotensin II signal played an important
role in mRen gene suppression. We propose that in a hypertensive environment, the
activity of this novel enhancer is attenuated, and, as a consequence, mRen gene
transcription is suppressed to maintain blood pressure.
KEYWORDS renin angiotensin system, hypertension, homeostasis, genome editing,
transcription, enhancer
Precise regulation of gene expression is coordinated by the combinatorial activity ofmultiple cis-regulatory elements. Among these, enhancers play a central role in
deﬁning spatiotemporal speciﬁcity as well as an appropriate response to environ-
mental cues in gene transcription, and therefore perturbation of enhancer activity
leads to developmental failures and disease (1). Enhancer regions are frequently
associated with characteristic chromatin signatures, such as acetylation of histone H3
lysine 27 (H3K27ac) and DNase I hypersensitivity (2). As anticipated, these enhancer
landscapes dynamically change in response to environmental stimuli to ﬁne-tune the
transcriptional output of their target genes (3, 4). Technologies detecting these en-
hancer marks have been combined with next-generation DNA sequencing to discover
huge numbers of putative enhancer elements (5). Furthermore, genome-wide associ-
ation studies of single-nucleotide polymorphisms (SNPs) and traits have identiﬁed
many disease-associated sequence permutations in putative enhancer regions (6).
Although these variants might affect disease susceptibility by inﬂuencing transcrip-
tional output and can be novel therapeutic targets, their functions and targets are
incompletely characterized.
The renin-angiotensin system (RAS) is a regulatory cascade that plays a major
physiological role in blood pressure (BP) regulation and electrolyte homeostasis. The
ﬁrst and rate-limiting step in this cascade is a proteolysis of angiotensinogen (AGT) by
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the aspartyl protease renin, which generates the decapeptide angiotensin I (AI). AI is
further converted by angiotensin-converting enzyme (ACE) into the vasopressor octa-
peptide, angiotensin II (AII). Through binding to its receptors, AII mediates a variety of
physiological effects such as vasoconstriction, increasing cardiac output and promoting
aldosterone synthesis. Because increased renin expression leads to blood pressure
elevation, its transcription is ﬁnely regulated by various physiological stimuli to main-
tain blood pressure homeostasis (7). For example, renin gene transcription is activated
and suppressed in hypotensive and hypertensive environments, respectively, in vivo
(8–10).
Renin is mainly synthesized in juxtaglomerular (JG) cells of the kidney, located in the
wall of afferent arterioles of glomeruli, and its transcription is under feedback regula-
tion of baroreceptors, macula densa signals, renal sympathetic nerve activity, and
tubular sodium load (11). While upregulation of renin gene transcription by intracellular
cAMP abundance thorough its responsive sequences in the promoter and enhancer
elements is relatively well established (11, 12), the mechanisms controlling its feedback
transcriptional suppression are poorly understood. One of the well-characterized cis-
regulatory elements of the renin gene is the mouse distal enhancer (mdE), located 2.6
kb 5= of the mouse renin (mRen) transcriptional start site (TSS) (13). The mdE bears
clustered binding sites for multiple transcription factors, including a cAMP-responsive
element (CRE), and contributes 80% of basal renin promoter activity in vivo (14, 15). In
an ACE inhibitor-induced hypotensive state, the mdE plays an essential role in full
induction of renin gene transcription (15). On the other hand, although the basal
expression level of the mdE-null mRen transgene (Tg) was much lower than that of the
wild type (WT), its expression was further suppressed in the hypertensive state (9),
demonstrating that mdE was dispensable for hypertension responsiveness. There exist
several sequence elements 5= to mdE that are conserved between the mouse and
human genomes (Ensembl and UCSC genome browsers [16, 17]). It is therefore possible
that currently uncharacterized regulatory elements reside within this upstream region
and contribute to responsive regulation of the renin genes.
We previously generated a mouse model of AII-induced hypertension (the Tsukuba
hypertensive mice [THM]) that overexpresses both a 15-kb human RENIN (hREN)
transgene (Tg) bearing 2.8 kb of 5=-ﬂanking sequence and a 14-kb human ANGIO-
TENSINOGEN (hAGT) Tg (18). Because of strict species speciﬁcity of the reaction between
renin and angiotensinogen (19), transgenic mice (TgM) bearing either hREN or hAGT Tgs
alone exhibit a normal blood pressure phenotype (18). In contrast, because the amino
acid sequence of AI that is generated by hREN and hAGT activity is identical to that of
the mouse, excess AI in the THM leads to AII overproduction that is catalyzed by murine
ACE. In this hypertensive mouse, we found that expression of the hREN Tg was
inappropriately upregulated, possibly due to the lack of a putative hypertension-
responsive element in the 15-kb hREN Tg sequence (9). In accord with this hypothesis,
it has been reported that a compound transgenic mouse bearing both the 45-kb hREN
Tg with a 25-kb 5=-ﬂanking region and the 14-kb hAGT Tg was normotensive (20),
suggesting that the 45-kb hREN sequence bore sufﬁcient sequence information to
appropriately suppress its expression in a hypertensive environment. Subsequently, we
demonstrated, by generating and comparing the activities of TgM lines carrying a
156-kb mRen bacterial artiﬁcial chromosome (BAC) Tg and 13-kb mRen Tg (9), that the
hypertension-responsive element of the mRen gene was located far from the tran-
scribed structural gene. Furthermore, we employed a CRISPR/Cas9 genome editing
strategy to delete the upstream 63-kb region (kb 3 to 66 of TSS) of the mRen gene
and demonstrated that a cis suppressor element in the hypertensive state must be
located within this region (9).
In this study, we localized the hypertension-responsive sequence of the mRen gene
using genome editing in vivo and found that a novel enhancer element was involved
in mRen transcriptional attenuation in a hypertensive state. Luciferase (Luc) reporter
analysis in the immortalized, mRen-expressing JG cell line As4.1 (21) was used to deﬁne
two enhancer core elements, one of which colocalized with a DNase I hypersensitive
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site (HS) and was enriched for an H3K27ac-activating histone mark. Finally, removal of
one, but not the other, enhancer candidate from the endogenous mRen gene dramat-
ically reduced its basal expression level and abrogated its transcriptional response to a
hypertensive environment. This ﬁnding sheds light on the unexplored distal regulatory
region of the mRen gene and provides in vivo evidence that a novel 5= enhancer plays
an essential role in the physiological response to an AII-induced hypertensive environ-
ment.
RESULTS
The role of angiotensin II receptor signaling in renin gene suppression in THM.
We ﬁrst determined which of the signals, i.e., high blood pressure (BP) and/or increased
AII level (18), was responsible for downregulation of renin gene expression in THM
transgenic animals. We treated THM with either hydralazine, a RAS-independent va-
sodepressor, or olmesartan (Olm), an angiotensin II (AII) receptor (AT1) blocker to lower
their BP within the normotensive range (Fig. 1A). After a 1-day administration of either
drug, kidneys were collected and subjected to gene expression analysis. As shown in
our previous work (9), endogenous mRen transcription was lower in THM than in
control mice (Fig. 1B). While endogenous mRen gene expression was still lower in the
hydralazine-treated THM, that of the olmesartan-treated THM was derepressed (Fig. 1B).
These results indicate that AII receptor signaling plays an indispensable role in renin
gene suppression in THM.
Generation of large 3= and short 5= deletion alleles of the endogenous mRen
gene by CRISPR/Cas9 genome editing. We have previously shown that DNA se-
quences involved in mRen gene suppression in THM (i.e., hypertensive environment)
resided within 63 kb 5= to the gene (Fig. 2, 5=-large-del) (9). However, since two
neighboring genes (Plekha6 and Kiss1) are located within the 63-kb region (Fig. 2), we
could not discriminate whether the sequences were operating in cis as negative
regulatory elements or in trans through their gene product(s). In addition, any possible
role for mRen 3=-ﬂanking sequences remained unknown. We therefore generated two
mutant alleles of the endogenous mRen gene using CRISPR/Cas9 genome editing. For
generating the large 3= deletion allele that lacked 78 kb of 3=-ﬂanking sequence
[Δ3=(78k)] (Fig. 2), a pair of guide RNAs (gRNAs) was designed to target 3= positions of
the 156-kb BAC Tg (9) and of the 13-kb Tg (9) to remove sequences between the two
target sites (Fig. 3A, right).
The other mutant allele lacked 17 kb of 5= ﬂanking sequences [Δ5=(17k)] (Fig. 2). It
has been reported that compound transgenic mice carrying both the 45-kb hREN Tg
and the hAGT Tg were normotensive and that their plasma levels of human renin
were appropriately suppressed, in contrast to the analogous case in THM (20, 22),
suggesting that the 45-kb hREN gene fragment contains a cis element(s) responsible
for hypertension-responsive suppression of transcription. Using the Ensembl genome
FIG 1 Drug administration to Tsukuba hypertensive mice. (A) Systolic blood pressure in Tsukuba
hypertensive mice (THM) administered olmesartan (Olm) or hydralazine (Hyd). (B) Expression levels of the
endogenous mRen gene in normotensive (control [Ctrl]) and THM male animals were analyzed by
qRT-PCR. Each value represents the ratio of mRen gene expression to that of Gapdh, and values are the
means  SD. The number of animals analyzed is shown in parentheses. Statistical differences were
determined using an unpaired t test (N.S., not signiﬁcant; *, P  0.05; **, P  0.01).
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browser (http://www.ensembl.org), we found that a 17-kb region of the mRen gene
between the 3= end of the Kiss1 gene and 5= to mdE was highly homologous to the
20-kb upstream region carried within the 45-kb hREN gene fragment (Fig. 2, top).
Therefore, guide RNAs were designed to delete and test for possible function of the
17-kb sequence (Fig. 3A, left). Following pronucleus injection of the targeting plasmids,
founder mice with the desired mutations were identiﬁed and veriﬁed by Southern
blotting and sequencing (data not shown). Germ line transmission of the mutant allele
FIG 2 Hypertension responsiveness of transgenes and endogenous mutant alleles. Shown is a schematic
representation of hREN and mRen transgenes and mRen mutant alleles. Conserved regions between
human and mouse are indicated by shading. Arrowed rectangles indicate transcriptional direction of the
genes. Reference numbers for previous studies are indicated with superscripts.
FIG 3 Generation of the Δ5=(17k) and Δ3=(78k) alleles by genome editing. (A) Partial restriction enzyme maps of the mouse
endogenous WT and mutant alleles. The Cas9 target sites for generating the Δ5=(17k) and Δ3=(78k) alleles are shown by
black and gray arrowheads, respectively. Targeting at two 5= upstream sites removes 17 kb of sequence of the mRen gene,
generating a 10-kb NcoI (vertical lines) restriction fragment in the mutant allele. Targeting at two 3= downstream sites
removes 78 kb of sequence, generating a 2.2-kb NcoI restriction fragment in the mutant allele. Probes used for Southern
blot analysis shown in panel B are indicated by rectangles (probes I and II). (B) DNAs from thymic cells of WT and mutant
animals were digested with NcoI, separated by electrophoresis, and hybridized to the probes shown in panel A. Shown on
the right of each panel are expected bands with their sizes (in kilobases). (C) Sequence alignment of WT (reference) and
mutant alleles conﬁrmed the 17-kb and 78-kb sequence deletions in the Δ5=(17k) and Δ3=(78k) alleles of the mRen gene,
respectively. Protospacer-adjacent motif (PAM) and gRNA sequences are shaded and underlined, respectively. Cleavage
sites predicted from PAM locations are indicated by arrowheads.
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was conﬁrmed in F1 offspring by Southern blotting and sequence analyses (Fig. 3A
to C).
Expression of the3=(78k) but not the5=(17k)mRen gene alleles was suppressed
in a hypertensive environment. In previous work, we generated a pseudo-WT allele, in
which a Flp recombinase target (FRT) sequence was inserted into the 3= untranslated
region of mRen (Fig. 2) to distinguish transcripts derived from the mutant and WT
alleles. Because the pseudo-WT allele was appropriately downregulated when intro-
duced into a hypertensive environment (9), it serves as a rigorous internal control. To
examine hypertension responsiveness of the deletion and the pseudo-WT alleles, these
alleles were combined and bred into normotensive or hypertensive (THM) animals (Fig.
4A). Total RNA was extracted from the kidneys, and the abundance of renin gene
transcripts from the endogenous deletion, as well as of the endogenous pseudo-WT
alleles, was determined by quantitative reverse transcription-PCR (qRT-PCR). In the
kidney of animals carrying the Δ3=(78k) allele (lines 1870 and 1875) (Fig. 4B), expression
of the pseudo-WT mRen gene was suppressed in THM, as predicted (Fig. 4B, left). In the
same set of samples, expression of Δ3=(78k) mRen gene was also suppressed, yet
the degree of suppression seemed less obvious (Fig. 4B, right). In contrast, while the
pseudo-WT mRen gene was appropriately suppressed in THM, the response of Δ5=(17k)
mRen gene was abolished (lines 1906 and 1951) (Fig. 4C). These results clearly dem-
onstrated that DNA sequences predominantly responsible for mRen gene suppression
in THM resided within the 17-kb 5= upstream region.
The 17-kb upstream mRen 5= region bears enhancer activity in a normotensive
environment. We next examined transcriptional modulation by the 17-kb upstream
and the 78-kb downstream sequences in a normotensive environment. Hypothetically,
FIG 4 Hypertension responsiveness of the Δ3=(78k) and Δ5=(17k) alleles. (A) To precisely test the hypertension responsiveness, a
deletion allele in combination with pseudo-WT allele was bred onto a normotensive (control) or hypertensive (THM) environment. (B
and C) Expression levels of the endogenous Δ3=(78k), Δ5=(17k), and pseudo-WT mRen alleles in the kidney of normotensive (control)
and hypertensive animals (THM) were analyzed by qRT-PCR. Each value represents the ratio of mRen gene expression to that of Gapdh, and
values are means  SD. The expression value of male control animals in each group was arbitrarily set at 100. The number of animals
analyzed is shown in parentheses below each panel. Statistical differences were determined using an unpaired t test (N.S., not
signiﬁcant; *, P  0.05; **, P  0.01).
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if an element was indispensable for efﬁcient transcription of the mRen gene, it would
be expected that other cis elements could compensate for the loss of its activity to
maintain normal blood pressure in homozygous mutant animals, and therefore the
effect of any deletion on mRen transcriptional activity would be masked. To avoid such
an undesirable outcome, either true wild-type or mutant deletion alleles were paired
with the pseudo-WT allele of mRen (Fig. 5A). In this setting, the pseudo-WT mRen gene
would behave as a balancer to maintain blood pressure, and therefore the effect of any
mutations would become observable. Total RNA was extracted from the kidneys, and
the abundances of mRen gene transcripts were compared between WT and deletion alleles
by qRT-PCR. The mRNA level of the Δ5=(17k) allele was signiﬁcantly lower than that of the
WT allele (Fig. 5B, left), while the levels of Δ3=(78k) and WT alleles were comparable (Fig. 5B,
right). These results indicate that the mRen 17-kb 5= region, but not the 78-kb 3= region,
carried enhancer activity in the normotensive state.
Localization of enhancer core activity within the mRen 5=-ﬂanking region. To
deﬁne the enhancer core element in the 17-kb upstream region, luciferase reporter
constructs bearing various 5=-ﬂanking mRen gene sequences were generated and
transiently transfected into As4.1 cells (Fig. 6A). Luciferase assays revealed that the
20.1-kb mRen promoter conferred 6-fold higher transcriptional activity than the 3.1-kb
construct, and this value gradually decreased with truncation of the 5=-ﬂanking region.
Notably, two distinct regions, kb 20.1 to 17.4 and kb 5.4 to 3.1 relative to the
transcription start site, contributed signiﬁcantly to enhancer activity. These two core
sequences were termed the 20E and 5E regions, respectively. To test their cell type
speciﬁcity, the 20.1-kb, 5.4-kb, and 3.1-kb mRen reporter constructs were also trans-
fected transiently into mouse embryonic ﬁbroblasts (MEF; non-renin-producing cells)
(Fig. 6B). Neither the 20E nor 5E sequence exhibited enhancer activity when tested
with the 3.1-kb mRen promoter, suggesting that the activities of these sequences might
be cell type speciﬁc.
We then tested the enhancer property of the 20E and 5E sequences. These
fragments were cloned upstream or downstream of the 3.1-kb mRen-Luc construct in
either plus or minus orientation (Fig. 6C and D). When cloned upstream of the
promoter, the 20E fragment enhanced its activity by 1.5-fold regardless of its orien-
FIG 5 The basal expression levels of the Δ5=(17k) and Δ3=(78k) alleles. (A) Compound heterozygous
mutant mice (pseudo-WT/WT and pseudo-WT/deletion allele) were generated to compare the expression
level of the WT allele to that of the deletion allele by the same primer set. (B) Expression levels of the
endogenous WT and deletion [Δ5=(17k) or Δ3=(78k)] mRen alleles in the kidney of normotensive animals
were analyzed by qRT-PCR. Each value represents the ratio of endogenous WT or deletion mRen gene
expression to that of Gapdh, and values are means  SD. The expression value of WT animals in each
group was arbitrarily set at 100. The number of animals analyzed is shown in parentheses below each
panel. Statistical differences were determined using an unpaired t test (N.S., not signiﬁcant; **, P  0.01).
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FIG 6 Identiﬁcation and characterization of mouse renin enhancer core elements in the 17-kb region. (A
to E) The 20.1-kb mRen 5=-ﬂanking region and its deletion mutants were linked to the luciferase reporter
gene (Luc) (A and B). The 20E or 5E fragment was linked to the Luc reporter under the control of the
3.1-kb mRen Tg (C and D) or SV40P (E). These reporter constructs, as well as the control plasmid
(Continued on next page)
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tation, while the activity was feeble when the fragment was cloned downstream (Fig.
6C). In contrast, the 5E fragment cloned upstream or downstream of the 3.1-kb
promoter activated its transcription by 2.5- or 2-fold, respectively, regardless of its
orientation (Fig. 6D). These results indicated that at least the 5E sequence could fulﬁll
the deﬁnition of a classical enhancer (23).
Finally, the 20E and 5E fragments were linked to the heterologous simian virus
40 promoter (SV40P), and their transcriptional activities were determined in As4.1 cells.
Both 20E and 5E fragments activated the SV40 promoter by 2- and 3-fold, respec-
tively, suggesting that these activating sequences had no promoter speciﬁcity (Fig. 6E).
DNase I hypersensitivity and H3K27ac histone marks colocalize with the 5E
element. To further explore the molecular mechanism of mRen gene regulation
through the 20E and 5E elements, we conducted DNase I hypersensitive site (HS)
mapping of the mRen gene locus in As4.1 and MEF cells (Fig. 7A). While no recognizable
hypersensitive sites were identiﬁed either within a 4.8-kb (kb20 to17) or 8.9-kb (kb
17 to 8) region relative to TSS of the gene (Fig. 7B and C), two hypersensitive sites
were found within the 7.9-kb (kb 7 to 1 of TSS) region (Fig. 7D). Based on our
ﬁner-mapping results with various restriction enzymes (data not shown), we con-
cluded that one of these sites corresponded to the mdE enhancer (13) and that the
other localized in the 5E region. We found that these HSs were quite faint in
non-renin-producing MEF cells (Fig. 7E) where no enhancer activity was detectable in
the reporter assay (Fig. 6B).
We then asked whether the 5E element was associated with the H3K27ac mark, a
typical enhancer signature. Consistent with the DNase I HS mapping result, chromatin
immunoprecipitation (ChIP)-qPCR analysis of the As4.1 chromatin revealed that the
H3K27ac mark was highly enriched at the5E site, as well as at the position of the mdE
element (Fig. 7H, black bars). On the other hand, such enrichment was not reported in
MEF cells (C57BL/6) (https://genome.ucsc.edu).
We next asked if AII treatment of the As4.1 cells would affect enrichment of the
H3K27ac mark around the enhancers. We found that AII-induced endogenous mRen
gene suppression in As4.1 cells was not particularly strong, probably because AII
receptor (AT1) expression in these cells is lower than that in the kidney JG cells.
Therefore, we transiently transfected an AT1a expression plasmid and treated the cells
with AII. As expected, endogenous mRen gene expression was suppressed in response
to increasing amounts of AII (Fig. 7G). In these cells, enrichment of the H3K27ac mark
was signiﬁcantly reduced, especially at around the 5E enhancer region (Fig. 7H).
These results demonstrated that the 5E region exhibited enhancer features in As4.1
cells, which became less obvious when cells were stimulated by AT1 signaling.
Generation of the 5E and 20E alleles of the endogenous mRen gene by
CRISPR/Cas9 genome editing. To elucidate the in vivo function of the 5E and 20E
sequences, we removed these enhancer core elements independently from the en-
dogenous mRen gene by CRISPR/Cas9 genome editing (Fig. 8A, Δ5E and Δ20E).
Following injection of two sets of targeting plasmids into pronuclei, founder mice with
the desired mutation were identiﬁed by Southern blotting and sequencing (data not
shown). Germ line transmission of the mutant alleles was conﬁrmed in F1 offspring by
Southern blotting and sequence analyses (Fig. 8B to D).
The5E element carries enhancer activity in a normotensive environment.We
ﬁrst examined the effect of deleting these elements on a basal level of transcription of
the mRen gene in a normotensive environment (Fig. 9). Quantitative RT-PCR analysis of
kidney mRNAs revealed that the expression level of mRen mRNA from the Δ5E allele
FIG 6 Legend (Continued)
CMV–-Gal, were cotransfected into As4.1 (A and C to E) or MEF (B) cells. Luciferase activities were
normalized by -Gal activities to control for transfection efﬁciencies. Values of the 3.1-kb mRen-Luc or
SV40P-Luc construct in each group were arbitrarily set at 1. Each value represents the means  SD for
three technical replicates in two independent experiments. Statistical differences were determined using
an unpaired t test (N.S., not signiﬁcant; **, P  0.01; ***, P  0.001; ****, P  0.0001).
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was much lower than that generated from the WT allele (Fig. 9, left), while deletion of
the 20E element had only a marginal effect (Fig. 9, right). These results indicated that
the 5E element carried signiﬁcant basal enhancer activity in vivo, consistent with the
results from the luciferase reporter assays conducted in As4.1 cells (Fig. 6).
FIG 7 DNase I hypersensitive site mapping and ChIP assay for H3K27ac in the mouse renin gene locus.
(A) Partial restriction enzyme map of the mRen allele. XmnI (X) and BamHI (B) sites are displayed as
vertical lines, and probes used for Southern blot analyses in panels B to E are shown as gray boxes
(probes IV to VI). The positions of HSs are indicated by upward arrows (5E-HS and mdE-HS). (B to E)
Nuclei were isolated from As4.1 (B to D) or MEF (E) cells and treated with increasing concentrations (conc)
of DNase I. DNA was then isolated and digested with XmnI (B, D, and E) or BamHI (C). After agarose gel
electrophoresis, the DNA was subjected to Southern blot analysis by using the probes shown in panel
A. Shown on the right of each panel are expected bands with their sizes. HS bands are indicated by
arrowheads. (F) The positions of the primer sets used for qPCR shown in panel H are indicated by black
boxes (primers A to G). (G) Relative expression levels of the endogenous mRen gene in As4.1 cells treated
with saline or 1 M or 100 M AII. Each value represents the ratio of mRen gene expression to that of Gapdh,
and values are means  SD. Expression value for the saline-administered animal was arbitrarily set at 100.
Statistical differences were determined using an unpaired t test (*, P  0.05; **, P  0.01). (H) Relative
enrichment of H3K27ac in As4.1 cells treated with saline or 1 M or 100 M AII. Quantitative PCR was
repeated at least three times for each sample, and fold enrichment of H3K27ac relative to that of the IgG
control (average values with standard deviations) was calculated and graphically depicted (value of negative
control without AII treatment was set at 1.0). A genomic region located in a gene desert on chromosome 6
served as a negative control. Statistical differences against the saline-administered sample in each site were
determined using an unpaired t test (*, P  0.05; **, P  0.01).
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Expression of the 20E but not the 5E mRen allele is suppressed in
hypertensive mice. The two mutant alleles were subjected to a hypertensive (THM)
environment, and their expression levels were determined by qRT-PCR analysis of
kidney mRNAs. In the animals carrying the Δ5E and the pseudo-WT alleles (lines 3043
and 3077) (Fig. 10A), expression of the pseudo-WT mRen gene was signiﬁcantly
suppressed in THM (Fig. 10A, left). Although expression of the Δ5E allele was also
suppressed in THM (Fig. 10A, right), the extent of suppression was markedly lower than
that of the pseudo-WT allele. In contrast, expression of the Δ20E allele was appro-
priately downregulated in THM, as was the case for the pseudo-WT allele (line 3124)
(Fig. 10B). To further clarify the role of the 5E sequence, the expression levels of
pseudo-WT and Δ5E alleles were displayed on the same panel after normalization for
the ampliﬁcation efﬁciency of each primer set (Fig. 10C). In accord with the above
results (Fig. 9), the expression of the Δ5E allele was strikingly lower than that of the
pseudo-WT allele in a normotensive environment. As a consequence of this attenua-
tion, the Δ5E allele lost almost all of its ability to downregulate mRen expression in
response to the hypertensive environment, which was conﬁrmed by the fact that there
was an interaction effect (two-way analysis of variance [ANOVA], P  0.001) between
genotype (pseudo-WT and Δ5E) and BP environment (control and THM) for mRen
mRNA expression. These results indicated that the5E enhancer core element plays an
FIG 8 Generation of the Δ5E and Δ20E alleles by genome editing. (A) Schematic representation of mRen
mutant alleles. The Cas9 target sites are shown by arrowheads. (B) Partial restriction enzyme maps of the mouse
endogenous WT and mutant alleles. The Cas9 targeting at two pairs of 5= upstream sites (arrowheads) removes
either a 2.3-kb (left panel) or 2.7-kb (right panel) sequence of the mRen gene, generating a 4.2-kb AseI or 3.4-kb
AvrII restriction fragments in the mutant alleles, respectively. Probes used for Southern blot analysis shown in panel
C are indicated by gray rectangles (probes I and III). (C) DNAs from tail tip of WT and mutant animals were digested
with AseI (left) or AvrII (right), separated by electrophoresis, and hybridized to the probes shown in panel B. Shown
on the right of each panel are expected bands with their sizes. (D) Sequence alignment of WT (reference) and
mutant alleles conﬁrmed the 2.3-kb and 2.7-kb sequence deletions in the Δ5E and Δ20E alleles of the mRen
gene, respectively. PAM and gRNA sequences are shaded and underlined, respectively. Cleavage sites predicted
from locations of the PAM are indicated by arrowheads.
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important role in mRen gene suppression in THM while the 20E element was
dispensable for this response.
Finally, THM carrying the Δ5E and the pseudo-WT alleles were treated with
olmesartan in the same manner as for the experiment shown in Fig. 1. After the
normotensive state was conﬁrmed in the THM (Fig. 10D, left), kidneys were collected
and subjected to gene expression analysis. While the level of mRen mRNA from the
pseudo-WT allele in olmesartan-treated THM (THM-Olm) was signiﬁcantly increased
(P  0.003 versus the level in THM), that of the Δ5E allele in THM-Olm remained
low (P  0.343 versus the level in THM; P  0.006 versus the control level) (Fig. 10D,
right), demonstrating that AT1 signaling modulates mRen gene expression via the 5E
enhancer element in the hypertensive environment.
DISCUSSION
Previous studies focusing on the proximal region of the mRen gene have identiﬁed
cis-regulatory elements contributing to its basal transcriptional activity; critically, any
element involved in the response to physiological stimuli has not been identiﬁed. In
this study, using CRISPR/Cas9 genome editing, we showed that the 17-kb region 5= to
the well-characterized mdE carried novel enhancer activity, and we hypothesized that
this enhancer was a part of a hypertension-responsive mechanism. We then ﬁnely
localized the responsible element and demonstrated that a 2.3-kb 5E enhancer core
element played a pivotal role in hypertension responsiveness in vivo. Based on our
results, we propose that, in the normotensive environment, the 5E element functions
as an enhancer and is involved in full activation of mRen gene transcription. In the
hypertensive state, the enhancer activity somehow becomes attenuated by AT1 sig-
naling, and, as a consequence, transcription of the mRen gene is suppressed (Fig. 11).
To assess the role of mdE in mRen gene expression, we previously employed an
mRen BAC (156-kb) transgene carrying either WT or null mdE sequence. We found that
the expression level of the mdE-null mRen Tg in the normotensive state (20% of WT,
comparable to that seen with the Δ5E mRen allele) (Fig. 9) was further suppressed
(5-fold) in THM (9), which is apparently distinct behavior from that with the Δ5E
mRen allele. Therefore, we concluded that the 5E enhancer, but not the mdE, is the
main target of hypertension-induced transcriptional attenuation. On the other hand,
since expression of the Δ5E allele was still signiﬁcantly attenuated in the hypertensive
state (Fig. 10A), another element(s) may also be involved in the homeostatic response.
Although data from chromatin immunoprecipitation with DNA sequencing (ChIP-
seq) in As4.1 cells are unavailable, the data in murine erythroleukemia (MEL) cells that
FIG 9 The basal expression levels of the Δ5E and Δ20E alleles. Expression levels of the WT and
deletion (Δ5E or Δ20E) mRen alleles in the kidney of normotensive animals were analyzed by
qRT-PCR. Each value represents the ratio of endogenous WT or deletion mRen gene expression to that
of Gapdh, and values are means  SD. The expression value of WT animals in each group was arbitrarily
set at 100. The number of animals analyzed is shown in parentheses below each panel. Statistical
differences were determined using an unpaired t test (*, P  0.05; **, P  0.01).
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weakly express the mRen gene are available (https://genome.ucsc.edu). While the
H3K27ac mark was signiﬁcantly enriched at the 5E region of the mRen gene, it was
not abundantly enriched at the mdE or promoter region in MEL cells. Because we found
the mark signiﬁcantly enriched at all three regions, i.e., 5E, mdE, and the promoter, in
FIG 10 Hypertension responsiveness of the Δ5E and Δ20E alleles. (A and B) Expression levels of the endogenous Δ5E,
Δ20E, and pseudo-WT mRen alleles in the kidney of normotensive (control) and hypertensive (THM) animals were
analyzed by qRT-PCR. Each value represents the ratio of mRen gene expression to that of Gapdh, and values are means 
SD. The expression value of male control animals in each group was arbitrarily set at 100. The number of animals analyzed
is shown in parentheses below each panel. Statistical differences were determined using an unpaired t test (**, P  0.01).
(C) Expression levels of the endogenous pseudo-WT and Δ5E mRen alleles were exhibited on the same panel after
normalization by ampliﬁcation efﬁciency of each primer pair. The expression value of the pseudo-WT in male control
animals in each line was arbitrarily set at 100. There was an interaction effect (two-way ANOVA; ***, P  0.001) between
deletion of the 5E (pseudo-WT and Δ5E) and genotype (control and THM). (D) Systolic blood pressure in THM
administered olmesartan is shown in the left panel. In the right panel, expression levels of endogenous pseudo-WT or
Δ5E mRen alleles in the kidney of normotensive (control), THM, and olmesartan (Olm)-treated THM male animals were
analyzed by qRT-PCR and exhibited after normalization by ampliﬁcation efﬁciency of each primer pair. Each value
represents the ratio of mRen gene expression to that of Gapdh, and values are means  SD. The expression value of the
pseudo-WT allele in control animals was arbitrarily set at 100. The number of animals analyzed is shown in parentheses.
Statistical differences were determined using an unpaired t test (N.S., not signiﬁcant; **, P  0.01).
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As4.1 cells (Fig. 7H), high-level expression of the mRen gene may require synergy of
both enhancers: a notion consistent with our previous (mdE-null TgM [9]) and current
(Δ5E) (Fig. 9) in vivo results. On the other hand, DNase I HSs were found in both the
5E and mdE regions in MEL cells (https://genome.ucsc.edu) and As4.1 cells (Fig. 7D).
It is therefore formally possible that DNase I HSs is associated with chromatin archi-
tecture (i.e., CTCF binding, discussed below), rather than the enhancer feature per se, at
least at the mdE site (Fig. 7D).
The mechanism of how the 5E enhancer element, located 5 kb upstream of the
TSS, remotely activates the mRen gene promoter is currently unknown. Around both
the 5E HS and mRen TSS regions, we found consensus binding sites for CTCF
(CCCTC-binding factor), a well-known chromatin architectural protein that can facilitate
long-range enhancer-promoter interactions, as well as generate a chromatin boundary
(24). According to the ChIP-seq data in MEL cells (https://genome.ucsc.edu), CTCF
binding is reported around the 5E region. Therefore, the 5E distal enhancer may
physically associate with the proximal promoter via loop formation to potentiate mRen
gene transcription. In addition, we found that H3K27ac enrichment and its response to
AII treatment in As4.1 cells are quite different at the primer recognition sites C and D
(Fig. 7F) within the 5E region (where presumptive CTCF binding site is located),
suggesting a presence of chromatin boundary at this position.
Because mdE and5E HS were not observed in non-renin-producing MEF cells (Fig.
7E), they may be part of the clustered enhancer elements important for deﬁning JG cell
identity through potentiating mRen gene transcription. In situ hybridization analysis of
mdE knockout mice revealed that the signal intensity of mRen was diminished yet still
existed in JG apparatuses (25). Therefore,5E enhancer may redundantly contribute to
shape JG cell identity. Interestingly, the5E region bears a consensus binding motif for
RBP-J (26), a Notch-responsive transcription factor that is critically important for acqui-
sition and/or maintenance of JG cell phenotype. RBP-J conditional knockout mice
generated by using a Ren-1D-Cre driver displayed a severe reduction in the number of
renin-positive cells, low renal mRen mRNA, and low circulating renin (27). In general,
activation of Notch receptor leads to the release of its intracellular domain (NICD),
which interacts with the RBP-J and potentiates gene expression via recruiting coacti-
vators, including the histone acetyltransferase p300 (28). Both CBP (CREB-binding
protein) and p300, well-known coactivators for cAMP-mediated gene regulation, are
required for mRen gene transcription in a chromatinized template (29) and establish the
active enhancer-associated histone mark, H3K27ac (30). Therefore, NICD/RBP-J complex
may contribute to establishment of the H3K27ac mark at the mRen locus. While recent
study of mRen BAC TgM indicated that the RBP-J binding site in the proximal promoter
region is critical for maintenance of mRen gene expression (31), the 5E enhancer
function may also be, at least in part, contributed by RBP-J activity.
FIG 11 Model of the enhancer-mediated regulatory mechanism of mouse renin gene transcription in a
hypertensive environment. In the normotensive state, the 5E enhancer activates mRen gene transcrip-
tion. In the hypertensive state, the AII signal devitalizes the5E enhancer activity, and, as a consequence,
mRen gene transcription becomes attenuated.
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According to genome-wide association studies of SNPs and traits, many disease-
associated variants are located in putative enhancer regions. We previously demon-
strated that a 15-kb human REN (hREN) Tg exhibited inappropriate responses to a
hypertensive environment (9). Combined with another report showing that a 45-kb
hREN Tg with its 25-kb 5=-ﬂanking region likely exhibited appropriate responses to a
hypertensive environment (20), we proposed that conserved distal elements in both
mouse and human renin genes regulated hypertension responsiveness. In the current
work, we demonstrated that the 17-kb region containing the 5E enhancer core
element played a crucial role in this regulation in mice (Fig. 4 and 10). Because the
homology search analyses revealed that sequences around the 20E and 5E regions
are highly conserved between humans and mice, the 5E homologous sequence in
humans may also have an important physiological function. In this regard, it is curious
that the SNP (rs11240692) associated with essential hypertension was reported to be
located within the 5E homologous sequences in human (32).
In summary, we demonstrated that hypertension-responsive regulation of the mRen
gene was mediated by a novel 2.3-kb enhancer core element (5E) located upstream
of the mdE. Precise regulation of enhancer activity could play a crucial role in devel-
opment and disease (1). Therefore, understanding of this enhancer-mediated transcrip-
tional modulatory mechanism for mRen gene transcription has a broad impact on not
only the RAS ﬁeld but also enhancer biology in general. In addition, the mRen enhancer
core sequence is fairly conserved in the hREN gene, and an essential hypertension-
related SNP is found in this region. Our ﬁndings thus shed light on the unexplored distal
regulatory region of renin genes and provide a novel mechanistic insight into renin
gene regulation.
MATERIALS AND METHODS
Animal procedures. Most inbred mouse strains are classiﬁed into two groups in terms of renin
alleles: one carrying a single renin gene, Ren-1C (e.g., C57BL/6) and another carrying two genes, Ren-2 and
Ren-1D in close proximity (e.g., DBA/2). Although the tissue speciﬁcities of Ren-1 and Ren-2 gene
expression are not precisely identical because of variations in their 5= regulatory sequences, the genes
are expressed at approximately equal levels in JG cells of the kidney (33). We used C57BL/6J mice
(carrying the Ren-1C gene) in this study. In addition, Ren-1C sequences were used for luciferase reporter
constructions, and both As4.1 (21) and MEF cells were derived from an Ren-1C mouse strain.
Mice were housed in a pathogen-free barrier facility in a 12-h light/12-h dark cycle and fed standard
rodent chow. THM were treated with olmesartan (10 mg/liter; kind gift from Daiichi Sankyo, Tokyo,
Japan) (34) or hydralazine hydrochloride (5 mg/liter) (H1753; Sigma, MO, USA) in drinking water for
24 h.
Blood pressure was measured by a programmable sphygmomanometer (BP-98A; Softron, Tokyo,
Japan) using the tail cuff method, as previously described (8). In each compound animal, higher systolic
blood pressure in the THM background than in the control was conﬁrmed (Table 1).
Animal experiments were performed in a humane manner under approval from the Institutional
Animal Experiment Committee of the University of Tsukuba. Experiments were performed in accordance
with the Regulation of Animal Experiments of the University of Tsukuba and the Fundamental Guidelines
TABLE 1 Comparison of systolic blood pressure values between control and THM animals
Deletion
mutant Line
SBP by group (mm Hg [n])a
Male Female
Control THM Control THM
Δ3=(78k) 1870 105.2 6.7 (7) 124.5 18.7 (4)* 101.7 4.7 (6) 131.6 10.3 (3)**
1875 103.3 3.7 (6) 123.6 9.8 (3)** 103.3 7.8 (7) 123.9 3.0 (4)**
Δ5=(17k) 1906 102.8 6 (7) 129.4 13.8 (11)** 106.8 4.1 (3) 131.1 15.2 (9)**
1951 98.5 4.4 (6) 121.3 14.5 (8)** 100.0 4.6 (6) 127.2 8.4 (5)**
Δ5E 3043 110.4 5.2 (4) 119.9 5.4 (5)** 99.1 2.7 (5) 119.6 4.0 (5)**
3077 99.9 4.4 (5) 126.1 12.0 (5)** 99.8 4.1 (6) 125.9 6.4 (4)**
Δ20E 3124 102.5 3.0 (5) 120.8 3.9 (4)** 101.9 3.9 (5) 125.9 12.0 (6)**
aSBP, systolic blood pressure; n, number of animals. Signiﬁcance was determined by an unpaired t test
between results for control mice and THM. *, P  0.05; **, P  0.01.
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for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions under
the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Generation of mutant alleles by CRISPR/Cas9 genome editing. The oligonucleotides were an-
nealed, phosphorylated, and ligated to the BbsI site of pX330 (plasmid 42230; Addgene) (35) for
generating Cas9/sgRNA expression vectors. In the following sequences, overhanging nucleotides are
shown in lowercase letters. For the Δ3=(78k) allele, the sequences for the 5= border are 5=-caccGAGGC
AGAGGCAAGAAGGATC-3= and 5=-aaacGATCCTTCTTGCCTCTGCCTC-3=; for the 3= border they are 5=-cac
cGTCCTACAGATACCAAGCGCT-3= and 5=-aaacAGCGCTTGGTATCTGTAGGAC-3=. For the Δ5=(17k) allele, the
sequences for the 5= border are 5=-caccGCTCTCAAATTCTGGGATTAA-3= and 5=-aaacTTAATCCCAGAATTT
GAGAGC-3=; for the 3= border they are 5=-caccGAGGGAGAAATAAAGTAGGTG-3= and 5=-aaacCACCTACT
TTATTTCTCCCTC-3=. For the Δ5E allele, the sequences for the 5= border are 5=-caccGGGCTAGCCCGCT
TTCTGCT-3= and 5=-aaacAGCAGAAAGCGGGCTAGCCC-3=; for the 3= border they are 5=-caccGAGGGAGA
AATAAAGTAGGTG-3= and 5=-aaacCACCTACTTTATTTCTCCCTC-3=. For the Δ20E allele, the sequences for
the 5= border are 5=-caccGCTCTCAAATTCTGGGATTAA-3= and 5=-aaacTTAATCCCAGAATTTGAGAGC-3=;
for the 3= border they are 5=-caccGTCAAAGCTGGATACGTAGGG-3= and 5=-aaacCCCTACGTATCCAGCTTT
GAC-3=.
The plasmids were microinjected into the pronuclei of fertilized eggs of C57BL/6J mice (Charles River
Laboratories Japan, Kanagawa, Japan). Tail DNA from founder offspring was screened by PCR and
Southern blot analyses. For Southern blot analysis of mutant alleles, thymus [Δ3=(78k) and Δ5=(17k)] or
tail (Δ5E and Δ20E) DNAs were treated with NcoI [Δ3=(78k) and Δ5=(17k)], AseI (Δ5E), or AvrII
(Δ20E) and fractionated by agarose gel electrophoreses. Following capillary transfer onto nylon
membranes, blots were hybridized with -32P-labeled DNA probes corresponding to the following
sequences: probe I [Δ5=(17k) and Δ5E], nucleotides [nt] 87271 to 87783; probe II [Δ3=(78k)], nt 98147
to 98713; probe III (Δ20E), nt 67565 to 68128 (GenBank accession number AC068906).
Reporter plasmid construction. Reporter plasmids were generated based on a PGV-B2 or PGV-P2
vector (Toyo Ink, Tokyo, Japan). The 3.1-kb and 20.1-kb mRen 5=-ﬂanking sequences were subcloned from
the BAC clone (RPCI23-240P23FRT) (36) using a prophage recombination system (37). For retrieving
3.1-kb sequences, 5= and 3= homology arms were PCR ampliﬁed using the following primer sets and
the BAC DNA as a template: 5= homology, 5=-AAAGGCGCGCCGCAACCACTCTCGAGCAGCAATGGCAG-3=
(BssHII and XhoI sites, respectively, are underlined) and 5=-CCAGGATCCAGGTATCAAGTAATAAGGAG-3=
(BamHI site is underlined); 3= homology, 5=-AGTGGATCCGGGCAGACAGCAGGGGAAGG-3= (BamHI site is
underlined) and 5=-TCAGCTCGAGCTTTCTAAGAGCTGTGTAG-3= (XhoI site is underlined).
These 5= and 3= homology fragments were digested with BssHII/BamHI and BamHI/XhoI, respectively,
and concomitantly ligated to the MluI-XhoI site of PGV-B2.
For 20.1-kb sequences, the 5= homology arm was PCR ampliﬁed using the following primer set and
the BAC DNA as a template: 5=-TTCTACGCGTAAAGGCGTGTGTTCCACCA-3= and 5=-CTCGGATCCTATCGG
TCCCCCAGAGCAG-3= (MluI and BamHI sites, respectively, are underlined).
Following MluI/BamHI digestion, the 5= homology fragment, together with the above-mentioned 3=
homology fragment (BamHI-XhoI) was ligated to MluI-XhoI sites of PGV-B2.
The resultant plasmids were linearized with PvuII and used to transform Escherichia coli cells (EL250;
a gift from N. A. Jenkins, National Cancer Institute, MD) harboring the renin gene BAC. After antibiotic
selection with ampicillin, transformants that underwent accurate homologous recombination were
identiﬁed by restriction enzyme digestion and DNA sequencing (20.1-kb mRen-Luc and 3.1-kb mRen-Luc)
(Fig. 6A).
For construction of a series of 5= deletion mutants of the mRen 5=-ﬂanking region, plasmid expressing
20.1-kb mRen-Luc was digested with MluI (at kb 20.1 relative to the TSS of the gene) and one of the
following restriction enzymes: SnaBI (kb17.4), AﬂII (kb15.8), PacI (kb10.8), NdeI (kb7.5), NheI (kb
5.4); this construct was blunt ended and self-ligated. The 13.0-kb mRen promoter fragment was
occasionally obtained during the 15.8-kb fragment construction.
The reporter plasmids containing the putative enhancer fragments downstream of the mRen
promoter were generated as follows. The 20E putative enhancer fragment was recovered from the
20.1-kb mRen Luc by digestion with MluI/SnaBI, blunt ended, ligated to the BamHI linker (TaKaRa Bio),
and digested with BamHI. The fragment was inserted in the BamHI site of the 3.1-kb mRen Luc to
generate 3.1-kb mRen-Luc with 20E in the plus or minus orientation (Fig. 6C). The 5E fragment was
PCR-ampliﬁed using the following primer set: 5=-CACAACGCGTAGATCTGCTAGCCCAGAGACATCTGAC-3=
and 5=-CACAACGCGTAGATCTCTCACCTACTTTATTTCTCCCTC-3= (MluI and BglII sites are underlined and in
boldface, respectively). The product was digested with BglII and inserted in the BamHI site of 3.1-kb
mRen-Luc to generate 3.1-kb mRen-Luc with 5E in the plus or minus orientation (Fig. 6D).
The reporter plasmids containing the putative enhancer fragments upstream of the mRen promoter
were generated as follows. The KpnI site (located upstream of the mRen promoter) in the vector portion
of the 3.1-kb mRen-Luc was converted to an MluI site by linker ligation. The 20E fragment was blunt
ended, ligated to the MluI linker, and digested with MluI. The5E fragment was also digested with MluI.
These putative enhancer fragments were cloned in the above-mentioned MluI site of the 3.1-kb
mRen-Luc to generate 3.1-kb mRen-Luc with the 5E or 20E in the plus or minus orientation (Fig. 6C
and D).
The 5E and 20E fragments were also cloned in the MluI site of the PGV-P2 to generate SV40P-Luc
with 5E or 20E fragment in the plus or minus orientation (Fig. 6E).
Cell culture and transfection. As4.1 cells, obtained from the American Type Culture Collection
(CRL2193), were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (049-32645; Wako, Osaka,
Japan) containing 10% fetal bovine serum (FBS) and penicillin-streptomycin.
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For luciferase assays, cells were seeded in 24-well plates at a density of 4  104 cells/well 12 h prior
to transfection. Equimolar amounts of test reporter plasmid, 25 ng of pCMV–-Gal (where CMV is
cytomegalovirus and -Gal is -galactosidase), and pUC19 (to make a total plasmid weight of 250 ng)
were introduced by using 0.75 l of Gene Juice transfection reagent (Millipore, MA). Forty-eight hours
after transfection, cells were harvested, and luciferase and -Gal activities (for the correction of variation
in transfection efﬁciencies) were measured by using a Centro XS3 LB 960 Microplate Luminometer
(Berthold Technologies, Bad Wilbad, Germany) and X-Mark spectrophotometer (Bio-Rad, CA), respec-
tively.
For AII treatment, cells were seeded in 24-well plates at a density of 3  104 cells/well at 24 h prior
to transfection. Twenty-four hours after pcDNA3-AT1a (250 ng) (38) transfection, cells were kept in
serum-free medium for 12 h. Cells were then stimulated by AII (Peptide Institute, Inc., Osaka, Japan) or
vehicle for 24 h and subjected to total RNA extraction or ChIP assay.
qRT-PCR. Total RNA was isolated from mouse kidney (from animals 2 to 3 months old) or As4.1 cells
using Isogen (Nippon Gene, Tokyo, Japan) and converted to cDNA using ReverTra Ace qPCR-RT master
mix with genomic DNA (gDNA) remover (Toyobo, Osaka, Japan). Quantitative ampliﬁcation of cDNA was
performed with a Thermal Cycler Dice real-time system (TaKaRa Bio, Shiga, Japan) using SYBR Premix Ex
Taq II (TaKaRa Bio). PCR primer sequences are as follows: endogenous mRen gene, 5=-GCCCTCTGCCAC
CCAGTAA-3= and 5=-CAAAGCCAGACAAAATGGCCC-3=; pseudo-WT mRen gene, 5=-CATCCACCGGATCTAG
ATAAC-3= and 5=-CAAAGCCAGACAAAATGGCCC-3=; and mouse Gapdh gene, 5=-AAAATGGTGAAGGTCGG
TGTG-3= and 5=-TGAGGTCAATGAAGGGGTCGT-3=.
DNase I hypersensitive site mapping. DNase I HS mapping was essentially carried out as described
elsewhere (39). In short, nuclei prepared from cultured cells were digested with increasing concentra-
tions of DNase I (2270A; TaKaRa Bio) at 37°C for 5 min. Puriﬁed DNA was cut to completion with
appropriate restriction enzymes and subjected to gel electrophoresis and Southern blotting. For map-
ping DNase I HSs, probes corresponding to following sequences were used: probe IV, nt 67922 to 68205;
probe V, nt 72762 to 72968; probe VI, nt 82815 to 83227 (GenBank accession number AC068906).
Chromatin immunoprecipitation (ChIP) assay. As4.1 cells were ﬁxed in phosphate-buffered saline
(PBS) with 1% formaldehyde for 10 min at room temperature. Nuclei (1.5  107 cells) were digested with
0.05 unit/l of micrococcal nuclease (ChIP-IT Express Enzymatic; Active Motif, MA) at 37°C for 15 min to
prepare primarily mononucleosome-sized chromatin. The chromatin was incubated with anti-H3K27ac
antibody (D5E4; Cell Signaling, MA) or normal rabbit IgG (02-6102; Invitrogen, CA) overnight at 4°C and
was precipitated with preblocked Dynabeads protein G magnetic beads (Life Technologies, CA). Immu-
noprecipitated materials were then washed extensively and reverse cross-linked. DNA was puriﬁed with
a QIAquick PCR puriﬁcation kit (Qiagen, Venlo, The Netherlands) and subjected to qPCR analysis. PCR
primer sequences are as follows: negative control, 5=-TTCCTTCCCTATTTGCTGCT-3= and 5=-CCCACCCCG
TCTAACTTTTA-3=; 20E (primer A on Fig. 7), 5=-GGGGTTGTTGAGGCAGAGAGGA-3= and 5=-GTGCCTGCC
TATAGTTTCTCTCACC-3=; 20E5E (B), 5=-AGGTGAAGGAAGAGGGGAATAGC-3= and 5=-TGGGTTTTGTC
ATCTCCTGTCCT-3=; 5E (C), 5=-GGTGGAGACAGAAGGAGCAAGAAAG-3= and 5=-CTCCAGGAACTGAAGTTA
CAGAGAG-3=; 5E (D), 5=-TACACGCAGGCAAAACACTCAGAC-3= and 5=-AGAGAGAGCCGCAGAGCAAGATC
A-3=; 5E (E), 5=-TGGCCCATTACCTGCTTTCTATATG-3= and 5=-GATTCAGGGCTTCTATTATGGTGATT-3=; mdE
(F), 5=-GCTCCCAACTTGCAGACTTCCC-3= and 5=-TCAGAGTACAGCCAGGTCACCA-3=l and promoter (G), 5=-
TGCCTGCCACCACTCTGCTCTG-3= and 5=-ACCTCCTTTATTTCCCCACGCCAG-3=.
Statistical analyses. Values are expressed as means  standard deviations (SD). The number of
animals analyzed is shown in each panel. Prism software (GraphPad Software, CA) was used for statistical
analysis. When only two groups were analyzed, statistical signiﬁcance was determined using an unpaired
t test. Two-way ANOVA was used to compare the effects of the 5E deletion (pseudo-WT versus Δ5E)
on BP environment (control and THM). Differences between results at a P value of0.05 were considered
statistically signiﬁcant.
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